Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Leukemia|September 6, 2013
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMTA Ruggeri, G Sanz, H Bittencourt, et al.
Bone Marrow Transplantation|April 2, 2025
Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TCM Peña, D F Martinez, A Paviglianiti, et al.
Vaccine|May 12, 2009
Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteriaM M Pérez, A Prenafeta, J Valle, et al.
Haematologica|October 17, 2001
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantationR Martino, M Rovira, E Carreras, et al.
Bone Marrow Transplantation|October 14, 2014
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCTR Parody, L Lopez-Corral, O L Godino, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Frontiers in Cell and Developmental Biology|March 15, 2021
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell TherapyC Ferreras, B Pascual-Miguel, C Mestre-Durán, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Pageof 12